Skip to main content

Day: April 8, 2020

Medtronic Provides Ventilator Progress Update

 FDA Authorizes Use of PB560 in the United States Company Launches PB980 Remote Capabilities Medtronic Expects Five-Fold Increase in Its Ventilator Production by End of JuneDUBLIN, April 08, 2020 (GLOBE NEWSWIRE) —  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced updates regarding its efforts to increase ventilator production around the globe. The company is announcing solid progress in the ramp-up of its ventilator production, as well as collaborating with technology partners and governments to drive new ventilator innovation and production, all in support of COVID-19 patients worldwide.

Continue reading

GENFIT Reports Full-Year 2019 Financial Results and Corporate Update

Topline interim results from Phase 3 clinical trial RESOLVE-IT expected by the end of May 2020Cash position of €277MM as of December 31, 2019 (vs €207MM as of December 31, 2018)Significant milestones achieved in 2019:Release of full dataset from the successful Phase 2 clinical trial of elafibranor in PBC, leading to “Breakthrough Therapy” and “Orphan Drug” designationsStrategic partnership with Terns Pharmaceuticals for the development and commercialization of elafibranor in Greater China, and strategic R&D agreement ($35MM upfront payment, and up to $193MM in milestones payment)Licensing agreement with LabCorp-Covance for NIS4, a non-invasive diagnostic tool for the identification of NASH patients with fibrosisGlobal offering and U.S. IPO on Nasdaq, raising gross proceeds totaling $155MMChange in governance and strengthening of US...

Continue reading

GENFIT : Résultats financiers annuels 2019 et point sur les activités de la Société

Résultats intermédiaires de l’essai clinique de Phase 3 RESOLVE-IT attendus d’ici fin mai 2020Position de trésorerie à 277MM€ au 31/12/2019 (vs 207MM€ au 31/12/2018)Avancées significatives en 2019 :Présentation des données complètes de l’essai positif de Phase 2 évaluant elafibranor dans la PBC, suivie de l’obtention des désignations « Breakthrough Therapy » et « Orphan Drug »Partenariat stratégique avec Terns Pharmaceuticals pour le développement et la commercialisation d’elafibranor dans la région Grande Chine, et accord stratégique de R&D (upfront de 35MM$, et jusqu’à 193MM$ en milestones)Accord de licence avec Labcorp-Covance pour NIS4, outil de diagnostic non-invasif pour l’identification de patients NASH avec fibroseCotation sur le Nasdaq, et levée de fonds associée pour un montant brut total de 155MM$ par voie d’augmentation...

Continue reading

Inventronics Announces 2019 Year End Financial Results

CALGARY, Alberta, April 08, 2020 (GLOBE NEWSWIRE) — Inventronics Limited (“Corporation”) (IVX:TSX Venture), a designer and manufacturer of custom enclosures for the telecommunications, electric transmission, cable television and other industries in North America, today announced its 2019 audited annual and unaudited 2019 Q4 financial results.For the year ended December 31, 2019, the Corporation reported net income of $195,000, or 4.4 cents per share, on revenue of $5,656,000 compared to a net income of $16,000, or 0.4 cents per share, on revenue of $4,616,000 for the 2018 fiscal year. For the three months ended December 31, 2019, the Corporation reported a net loss of $151,000, or 3.5 cents per share, on revenue of $947,000 compared to a net income of $189,000, or 4.3 cents per share, on revenue of $1,708,000, for the same period...

Continue reading

ALLEGIANCE BANCSHARES, INC. TO HOLD VIRTUAL ANNUAL MEETING

HOUSTON, April 08, 2020 (GLOBE NEWSWIRE) — Allegiance Bancshares, Inc. (NASDAQ: ABTX) (the “Company”), the holding company of Allegiance Bank (the “Bank”), today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and out of concern for the health and well-being of the Company’s employees and shareholders, its Annual Meeting of Shareholders, to be held on Thursday, April 23, 2020 at 1:30 p.m. Central Time, has been changed to a virtual meeting. Shareholders will not be able to attend the Annual Meeting in person this year.Shareholders are entitled to participate in the Annual Meeting if they were a registered shareholder as of the close of business on February 28, 2020, the record date, or hold a legal proxy for the meeting provided by the bank, broker or other nominee that...

Continue reading

Ferrari N.V.: 2020 Annual General Meeting

Maranello (Italy), 8 April 2020 – Ferrari N.V. (NYSE/MTA: RACE) (“Ferrari” or the “Company”) confirms that its Annual General Meeting of Shareholders (the “AGM”) will be held on 16 April 2020 in Amsterdam according to the previously announced agenda. Due to travel bans and local restrictions on meetings issued because of the Covid-19 outbreak, it is anticipated that executive directors will attend our AGM via remote connection. Furthermore, for health and safety reasons the Company will take several measures to minimize public health risks relating to the AGM and further measures will be introduced in the event local prescriptions should be amended. The Company, therefore, reserves the right to amend the physical arrangements on the day of the AGM, including refusing entry to the meeting to comply with health and safety requirements.As...

Continue reading

O-I Glass Business Update

PERRYSBURG, Ohio, April 08, 2020 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) today provided a business update in light of the rapid developments related to COVID-19. “O-I’s operating performance was solid during the first quarter of 2020, reflecting the positive impact of the company’s turnaround initiatives. While demand was stable for most of the quarter, shipment and production levels did decline in several markets in late March reflecting the impact of COVID-19. Importantly, glass packaging has been considered an essential element of the food and beverage value chain in most jurisdictions and end-use categories that O-I serves. As a result, the majority of our plants are operating with minimal interruption.  However, we have temporarily curtailed some capacity to adapt to revised customer demand and comply with governmental...

Continue reading

Mercury Systems Receives $4.7M Artificial Intelligence Processing Technology Order for Airborne Electro-Optic Application

ANDOVER, Mass., April 08, 2020 (GLOBE NEWSWIRE) — Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical technologies for aerospace and defense, announced it received a $4.7 million order from a leading defense prime contractor to provide artificial intelligence (AI) processing technology for integration into an advanced airborne electro-optic system. The order was booked in the Company’s fiscal 2020 third quarter and is expected to be shipped over the next several quarters.“Mercury solutions are designed to be the most rugged, durable and highest performing available to meet the rigorous demands of military and commercial customers,” said Joe Plunkett, Mercury’s Vice President and General Manager for Mercury’s Sensor Processing group. “Our ability to provide datacenter-quality processing...

Continue reading

22nd Century Group to Hold Virtual Annual Meeting of Stockholders

Williamsville, NY, April 08, 2020 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and development, announced today that the Company will hold its 2020 Annual Meeting of Stockholders using a virtual meeting format.  The decision to move to a virtual meeting was done in order to protect the health and safety of meeting participants during the coronavirus (COVID-19) pandemic. The meeting will take place on Friday, May 1, 2020 at 10:30 AM Eastern time. The live webcast will be available under the Events tab on the Investor Relations section of the Company’s website at www.xxiicentury.com and will be archived for at least 90 days.Stockholders of record at the close of business...

Continue reading

COSTCO WHOLESALE CORPORATION REPORTS MARCH SALES RESULTS

ISSAQUAH, Wash., April 08, 2020 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $15.49 billion for the retail month of March, the five weeks ended April 5, 2020, an increase of 11.7 percent from $13.87 billion last year.For the thirty-one weeks ended April 5, 2020, the Company reported net sales of $96.25 billion, an increase of 9.0 percent from $88.29 billion during the similar period last year.Comparable sales were as follows:Comparable sales excluding the impacts from changes in gasoline prices and foreign exchange were as follows:Additional discussion of these results is available in a pre-recorded telephone message. It can be accessed by dialing 1-855-859-2056 (conference ID 1985632). This message will be available through 5:00 p.m. (PT) on Wednesday, April...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.